[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Methylprednesolone cohort: Systemic steroids given pre-emptively at Day 5 in addition to the standard care:Methylprednisolone administered for 14 Days: 2 phases- prevention phase for 1 week followed by maintenance and tapering phase for 1 weekCategory 1:4- 8 mg Per Day If Minimal Initial Symptoms(Fever 100.5f; Bodyache; Headache; Sore Throat; HRCT 5%) Upgrade to Cat 2 If Symptoms Persist Beyond 3 Days or IncreasingCategory 2: 12-32 mg Per Day If Moderate Symptoms(Fever 100.5F \u00e2?? 103F; Loss of Smell/ Taste; Lethargy; Cough)Control Intervention1: Standard of care cohort: Protocol for mild cases of COVID-19 patients as delineated by AIIMS/ ICMR-COVID-19 National Task Force/JointMonitoring Group.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Methylprednesolone cohort: Systemic steroids given pre-emptively at Day 5 in addition to the standard care:Methylprednisolone administered for 14 Days: 2 phases- prevention phase for 1 week followed by maintenance and tapering phase for 1 weekCategory 1:4- 8 mg Per Day If Minimal Initial Symptoms(Fever 100.5f; Bodyache; Headache; Sore Throat; HRCT 5%) Upgrade to Cat 2 If Symptoms Persist Beyond 3 Days or IncreasingCategory 2: 12-32 mg Per Day If Moderate Symptoms(Fever 100.5F \u00e2?? 103F; Loss of Smell/ Taste; Lethargy; Cough)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Standard of care cohort: Protocol for mild cases of COVID-19 patients as delineated by AIIMS/ ICMR-COVID-19 National Task Force/JointMonitoring Group.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 798, "treatment_name": "Methylprednisolone", "treatment_type": "Corticosteroids", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Methylprednesolone cohort: Systemic steroids given pre-emptively at Day 5 in addition to the standard care:Methylprednisolone administered for 14 Days: 2 phases- prevention phase for 1 week followed by maintenance and tapering phase for 1 weekCategory 1:4- 8 mg Per Day If Minimal Initial Symptoms(Fever 100.5f; Bodyache; Headache; Sore Throat; HRCT 5%) Upgrade to Cat 2 If Symptoms Persist Beyond 3 Days or IncreasingCategory 2: 12-32 mg Per Day If Moderate Symptoms(Fever 100.5F \u00e2?? 103F; Loss of Smell/ Taste; Lethargy; Cough)Control Intervention1: Standard of care cohort: Protocol for mild cases of COVID-19 patients as delineated by AIIMS/ ICMR-COVID-19 National Task Force/JointMonitoring Group.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Methylprednesolone cohort: Systemic steroids given pre-emptively at Day 5 in addition to the standard care:Methylprednisolone administered for 14 Days: 2 phases- prevention phase for 1 week followed by maintenance and tapering phase for 1 weekCategory 1:4- 8 mg Per Day If Minimal Initial Symptoms(Fever 100.5f; Bodyache; Headache; Sore Throat; HRCT 5%) Upgrade to Cat 2 If Symptoms Persist Beyond 3 Days or IncreasingCategory 2: 12-32 mg Per Day If Moderate Symptoms(Fever 100.5F \u00e2?? 103F; Loss of Smell/ Taste; Lethargy; Cough)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Standard of care cohort: Protocol for mild cases of COVID-19 patients as delineated by AIIMS/ ICMR-COVID-19 National Task Force/JointMonitoring Group.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]